This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Extracorporeal Membrane Oxygenation Machine Market

Market Insights on Extracorporeal Membrane Oxygenation Machine covering sales outlook, demand forecast & up-to-date key trends

Extracorporeal Membrane Oxygenation Machinent Market By Product, Service Type, Component, Modality, Patient Type & Region - Forecast 2022 - 2032

Extracorporeal Membrane Oxygenation Machine Market Outlook (2022-2032)

[311 Pages Report] The global extracorporeal membrane oxygenation machine market size stood at US$ 531 Mn in 2021 and is expected to grow at a steady CAGR of 5% during the forecast period from 2022 to 2032, reaching a valuation of US$ 908 Bn by the end of 2032.

Rising adoption of extracorporeal membrane oxygenation machines is attributed to the increasing prevalence of chronic diseases and rapid growth in organ transplantation procedures worldwide.

Data Points

Market Insights

Extracorporeal Membrane Oxygenation Machine Market Value 2022

USD 531 Mn

Extracorporeal Membrane Oxygenation Machine Market Value 2026

USD 673 Mn

Extracorporeal Membrane Oxygenation Machine Market Projected Value 2032

USD 908 Mn

Extracorporeal Membrane Oxygenation Machine Market Forecast CAGR (2022-2032)

 

Key Players

Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (U.S.), Terumo Cardiovascular Systems Corporation, Livanova plc (U.K.), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed.

Rising complications during surgical procedures like heart transplants has prompted medical professionals to adopt innovative devices like extracorporeal membrane oxygenation machines in healthcare settings.

Extracorporeal membrane oxygenation machines are advanced medical devices used to provide prolonged cardiac and respiratory support to persons whose heart and lungs are unable to function properly. They have become ideal tools used in the care of adults and children with severe cardiac and pulmonary dysfunction.

These machines are mostly used when all the other medical options prove ineffective for patients whose lungs can’t provide enough oxygen to their body or can’t get rid of carbon dioxide. ECMO machines can also be used for patients undergoing heart or lung transplants.

Increasing prevalence of chronic diseases coupled with rapid surge in heart and lung transplants is emerging as a key factor in boosting the sales of extracorporeal membrane oxygenation machines and the trend is likely to escalate during the forecast period.

Leading extracorporeal oxygenation machine manufacturers are continuously innovating to develop advanced products that can help end users to effectively treat patients with heart or lung failures. For instance, in 2020, INTEGRIS Health and EMSA unveiled a one-of-a-kind specialty care ECMO ambulance.

Additionally, advancement in lung pulmonary airway disease treatment, presence of favorable reimbursement policies, and expansion of healthcare industry across developing regions of Asia and Africa will further expand the extracorporeal membrane oxygenation machine market size during the forthcoming years.

Customize this Report

Let us know your requirement to get
100% FREE customization

2015-2021 Market Demand Outlook For Extracorporeal Membrane Oxygenation Machine Market Compared To 2022-2032 Forecast

The global demand for extracorporeal membrane oxygenation machines is anticipated to grow at a moderate CAGR of 5% during the forecast period between 2022 and 2032. Growth in the market is driven by rising prevalence of cardiovascular and respiratory diseases, growing adoption of ECMO in lung and heart transplantation procedures, increase in the number of ECMO centers, and advancements in extracorporeal membrane oxygenation machines.

Extracorporeal membrane oxygenation has become one of the most widely used techniques for providing effective circulation and respiratory support in critically ill patients. It has emerged as an ideal alternative to cardiopulmonary bypass (CPB) used during organ transplantation procedures.

Increasing prevalence of chronic diseases such as COPD and along with the rise in the number of heart and lung transplantation procedures being performed is providing a major impetus to the extracorporeal membrane oxygenation machine market growth.

As per the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide in 2019, causing around 3.23 million deaths. This rise in mortality rate of respiratory and cardiovascular diseases will continue to expand extracorporeal membrane oxygenation machine market size during the forthcoming years.

Similarly, growing geriatric population and favorable government laws, investments, and initiatives are creating growth avenues within the global extracorporeal membrane oxygenation machine market.

ECMO machines offer various benefits such as higher speed and short processing times which is fueling their adoption across various end use verticals such as intensive care units, operating rooms, cardiac catheterization labs, and emergency departments.

The outbreak of COVID-19 created new opportunities for ECMO equipment manufacturers during the last few years. They become essential tools for improving the survival chances of severe COVID-19 patients.

What are the Challenges Faced by the Extracorporeal Membrane Oxygenation Machine Market?

There is no doubt that sales of extracorporeal membrane oxygenation machines are gathering huge across end use verticals. However, there are various factors that are slowing down the growth of extracorporeal membrane oxygenation machine market.

Some of these factors are the increasing extracorporeal membrane oxygenation machine prices due to frequent advancements, scarcity of qualified professionals, and low availability of these devices in some regions.

Country-Wise Insights

What Makes the U.S. Most Dominant Market for Extracorporeal Membrane Oxygenation Machines?

“Rise in Organ Transplantation Procedures Augmenting Demand for ECMO Machines in the U.S.”

As per FMI, the U.S. will continue to remain the most lucrative market for extracorporeal membrane oxygenation machines during the forecast period, owing to the rapidly developing healthcare sector, rising adoption of advanced technologies, surge in the number of lung cancer surgeries performed, heavy presence of leading medical device manufacturers, favorable government support, and increasing prevalence of chronic diseases.

The United States has one of the most developed and sophisticated healthcare industries in the world. Both government and non-government organizations are putting efforts to make advanced medical technologies available to healthcare professionals across the country. This will continue to generate lucrative opportunities for ECMO machine manufacturers during the forecast period.

Similarly, a sharp rise in the number of organ transplants is fueling the adoption of ECMO machines in the country. According to the Health Resource and Service Administration (HRSA), the number of heart transplants performed in adults alone rose to 3715 in 2020.

Why is Demand for Extracorporeal Membrane Oxygenation Machines Rising Across Japan?

“Rise in Organ Transplantation Procedures Creating Demand for ECMO Machines in Japan”

In recent years, demand for ECMO machines has risen at a significant pace across Japan and this trend is likely to continue during the forecast period, owing to the rising geriatric population, increasing healthcare spending, surge in chronic disease cases, booming organ transplant market, favorable government initiatives, and availability of advanced medical technologies.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Category-Wise Insights

Which Product is Top Selling Product in the Global Extracorporeal Membrane Oxygenation Machine Market?

“Demand for ECMO Machines to Remain High Throughout the Forecast Period”

By product, the global extracorporeal membrane oxygenation machine market has been segmented into ECMO machines and software. Among these, ECMO machines segment dominated the extracorporeal membrane oxygenation machine market in 2021 and is forecast to grow at a relatively higher CAGR over the assessment period.

Factors such as the growing popularity of portable ECMO devices, booming healthcare industry, and expansion of portable medical devices market are favoring the growth of this segment.

FMI’s latest extracorporeal membrane oxygenation machine market forecast indicates that demand for portable ECMO machines will rise at a substantial pace amid rising adoption of homecare medical devices across developed and developing regions.

Which Service Type Leads the Global Extracorporeal Membrane Oxygenation Machine Market?

“Application Segment to Account for Majority of Revenue Share”

Based on services type, extracorporeal membrane oxygenation machine market is segmented into application, middleware, and infrastructure. Among these, the application segment leads the market growth, accounting for the bulk of the revenue share generated in the market. Rising frequency of target diseases, increasing sales of ECMO machines, and technological improvements in ECMO machines contribute to the growth of this segment.

Which Component Contributes the Most to the Growth of Extracorporeal Membrane Oxygenation Machine Market?

“Sales of Controllers to Continue Rising in the Extracorporeal Membrane Oxygenation Machine Market”

As per FMI, the controllers segment is expected to dominate the extracorporeal membrane oxygenation machine market during the projected period. Rising adoption of controllers by end-users is a major factor triggering the growth of this segment.

By Modality Which Segment Holds the Largest Share in Extracorporeal Membrane Oxygenation Machine Market?

“Arterio-Venous Remains the Most Preferred Modality Type”

Latest extracorporeal membrane oxygenation machine market trends reveal that the arterio-venous segment will continue to lead the global extracorporeal membrane oxygenation machine market during the forecast period, owing to the various benefits such as highly effective nature and better medical evaluation associated with this technology.

Competitive Landscape

Leading extracorporeal membrane oxygenation machine manufacturers are constantly focusing on new product launches and approvals for expanding their product portfolios. Besides this, they have adopted growth strategies such as partnerships, acquisitions, mergers, joint ventures, and collaborations to gain a competitive edge in the global extracorporeal membrane oxygenation machine market.

For instance,

  • In 2020, the U.S. Food and Drug Administration (FDA) approved Novalung extracorporeal membrane oxygenation (ECMO) machine to treat acute respiratory or cardiopulmonary failure.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Extracorporeal Membrane Oxygenation Machine Market Report Scope

FMI’s latest market survey uncovers key investment pockets within the extracorporeal membrane oxygenation machine market. It analyses how key extracorporeal membrane oxygenation machine manufacturers are innovating to meet end user demands.

The study provides inclusive details about extracorporeal membrane oxygenation machine ecosystem and highlights key market governing factors such as growth drivers, restraints, and emerging opportunities. Besides this, it discusses in detail the latest extracorporeal membrane oxygenation machine market trends.

FMI also offers exhaustive research into factors pushing demand for extracorporeal membrane oxygenation machines across developed and developing regions. It attempts to explore the growth potential of regions with a high patient pool and explain how advancements in medical device technologies are affecting the extracorporeal membrane oxygenation machine sales.

Want to get a comprehensive assessment of extracorporeal membrane oxygenation machine market and much more? Keep in touch with “Future Market Insights”, one of the leading research companies of the world.

The Extracorporeal Membrane Oxygenation Machine Market analysis includes:

  • A 10-year realistic extracorporeal membrane oxygenation machine sales forecast across multiple verticals
  • Detailed analysis of regional pockets along with degree of market penetration
  • Impact of evolving respiratory devices on extracorporeal membrane oxygenation machine market forecast.
  • Exclusive recommendations on how to penetrate attractive ECMO machine markets of Asia, Africa, and others.
  • Insights into emerging end user demands and current extracorporeal membrane oxygenation machine market trends.
  • Top extracorporeal membrane oxygenation machine manufacturers and their growth strategies
  • Market dynamics including drivers, restraints, and emerging opportunities
  • Compelling insights into various products and services types in extracorporeal membrane oxygenation machines market.
  • Pricing analysis
  • The winning imperatives in extracorporeal membrane oxygenation machine market.

Attribute

Details

Forecast Period

2022-2032

Historic Data Available for

2015-2021

Market Analysis

USD Million for Value

Report Coverage

Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives

Key Segments Covered

By product, By Service Type, By Component, By Modality, By Patient Type, By Region

Key regions covered

North America

  • US
  • Canada
  • Rest of North America

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Western Europe

  • Germany
  • U.K.
  • France
  • Rest of Western Europe

Eastern Europe

  • Russia
  • Spain
  • Rest of Eastern Europe

South Asia Pacific

  • China
  • India
  • Japan
  • Malaysia
  • Thailand
  • Indonesia
  • South Korea
  • Rest of South Asia & Pacific

Middle East & Africa

  • GCC Countries
  • Turkey
  • Israel
  • Rest of MEA

Rest of the World

  • Oceania
  • Africa
  • South America

Patient Type

  • Neonates
  • Pediatrics
  • Adults

Key companies profiled

Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (U.S.), Terumo Cardiovascular Systems Corporation, Livanova plc (U.K.), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed.

Customization & pricing

Available upon request

Key Segments

By Product:

  • ECMO Machines
    • Portable Devices
    • Static Devices
  • Software

By Service Type:

  • Application
  • Middleware
  • Infrastructure

By Component:

  • Pumps
  • Oxygenators
  • Controllers
  • Cannula
  • Accessories

By Modality:

  • Veno-Venous
  • Veno-Arterials
  • Arterio-Venous

By Patient Type:

  • Neonates
  • Pediatrics
  • Adults

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global extracorporeal membrane oxygenation market was estimated to be worth US$ 531 Mn in 2021.

As per FMI, the global extracorporeal membrane oxygenation machine market is expected to grow at 5% CAGR during the forecast period, totaling US$ 908 Mn by 2032.

Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Terumo Cardiovascular Systems Corporation, Livanova plc (U.K.), Nipro Corporation (Japan) are some of the leading companies operating in the extracorporeal oxygenation machine market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Component

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) and Analysis By Component, 2015-2021

    8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Component, 2022-2032

        8.3.1. Pumps

        8.3.2. Oxygenators

        8.3.3. Controllers

        8.3.4. Cannul

        8.3.5. Assessories

    8.4. Market Attractiveness Analysis By Component

9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product 

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) and Analysis By Product , 2015-2021

    9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Product , 2022-2032

        9.3.1. ECMO Machines

            9.3.1.1. Portable Devices

            9.3.1.2. Static Devices

        9.3.2. Software

    9.4. Market Attractiveness Analysis By Product 

10. Global Market Analysis 2015-2021 and Forecast 2022-2032,By Provider

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) and AnalysisBy Provider, 2015-2021

    10.3. Current and Future Market Value (US$ Mn) and Analysis and ForecastBy Provider, 2022-2032

        10.3.1. Application

        10.3.2. Middleware

        10.3.3. Infrastructure

    10.4. Market Attractiveness AnalysisBy Provider

11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Modality 

    11.1. Introduction / Key Findings

    11.2. Historical Market Value (US$ Mn) and Analysis By Modality , 2015-2021

    11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Modality , 2022-2032

        11.3.1. Veno-Venous

        11.3.2. Veno-Arterials

        11.3.3. Arterio-Venous

    11.4. Market Attractiveness Analysis By Modality 

12. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Patient Type  

    12.1. Introduction / Key Findings

    12.2. Historical Market Value (US$ Mn) and Analysis By Patient Type  , 2015-2021

    12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Patient Type  , 2022-2032

        12.3.1. Neonates

        12.3.2. Pediatrics

        12.3.3. Adults

    12.4. Market Attractiveness Analysis By Patient Type  

13. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    13.1. Introduction

    13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021

    13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. Asia Pacific 

        13.3.5. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

            14.4.1.3. Rest of North America

        14.4.2. By Provider

        14.4.3. By Component

        14.4.4. By Product 

        14.4.5. By Modality 

        14.4.6. By Patient Type  

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Provider

        14.5.3. By Component

        14.5.4. By Product 

        14.5.5. By Modality 

        14.5.6. By Patient Type  

15. Latin America Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Brazil

            15.4.1.2. Mexico

            15.4.1.3. Rest of Latin America

        15.4.2. By Provider

        15.4.3. By Component

        15.4.4. By Product 

        15.4.5. By Modality 

        15.4.6. By Patient Type  

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Provider

        15.5.3. By Component

        15.5.4. By Product 

        15.5.5. By Modality 

        15.5.6. By Patient Type  

16. Europe Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. France

            16.4.1.3. U.K.

            16.4.1.4. Italy

            16.4.1.5. Russia

            16.4.1.6. Rest of Europe

        16.4.2. By Provider

        16.4.3. By Component

        16.4.4. By Product 

        16.4.5. By Modality 

        16.4.6. By Patient Type  

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Provider

        16.5.3. By Component

        16.5.4. By Product 

        16.5.5. By Modality 

        16.5.6. By Patient Type  

17. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

            17.4.1.4. Rest of Asia Pacific

        17.4.2. By Provider

        17.4.3. By Component

        17.4.4. By Product 

        17.4.5. By Modality 

        17.4.6. By Patient Type  

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Provider

        17.5.3. By Component

        17.5.4. By Product 

        17.5.5. By Modality 

        17.5.6. By Patient Type  

18. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021

    18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        18.4.1. By Country

            18.4.1.1. GCC Countries

            18.4.1.2. South Africa

            18.4.1.3. Turkey

            18.4.1.4. Rest of Middle East and Africa

        18.4.2. By Provider

        18.4.3. By Component

        18.4.4. By Product 

        18.4.5. By Modality 

        18.4.6. By Patient Type  

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Provider

        18.5.3. By Component

        18.5.4. By Product 

        18.5.5. By Modality 

        18.5.6. By Patient Type  

19. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. US Market Analysis

        19.2.1. Value Proportion Analysis by Market Taxonomy

        19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.2.2.1. By Provider

            19.2.2.2. By Component

            19.2.2.3. By Product 

            19.2.2.4. By Modality 

            19.2.2.5. By Patient Type  

    19.3. Canada Market Analysis

        19.3.1. Value Proportion Analysis by Market Taxonomy

        19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.3.2.1. By Provider

            19.3.2.2. By Component

            19.3.2.3. By Product 

            19.3.2.4. By Modality 

            19.3.2.5. By Patient Type  

    19.4. Mexico Market Analysis

        19.4.1. Value Proportion Analysis by Market Taxonomy

        19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.4.2.1. By Provider

            19.4.2.2. By Component

            19.4.2.3. By Product 

            19.4.2.4. By Modality 

            19.4.2.5. By Patient Type  

    19.5. Brazil Market Analysis

        19.5.1. Value Proportion Analysis by Market Taxonomy

        19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.5.2.1. By Provider

            19.5.2.2. By Component

            19.5.2.3. By Product 

            19.5.2.4. By Modality 

            19.5.2.5. By Patient Type  

    19.6. Germany Market Analysis

        19.6.1. Value Proportion Analysis by Market Taxonomy

        19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.6.2.1. By Provider

            19.6.2.2. By Component

            19.6.2.3. By Product 

            19.6.2.4. By Modality 

            19.6.2.5. By Patient Type  

    19.7. France Market Analysis

        19.7.1. Value Proportion Analysis by Market Taxonomy

        19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.7.2.1. By Provider

            19.7.2.2. By Component

            19.7.2.3. By Product 

            19.7.2.4. By Modality 

            19.7.2.5. By Patient Type  

    19.8. Italy Market Analysis

        19.8.1. Value Proportion Analysis by Market Taxonomy

        19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.8.2.1. By Provider

            19.8.2.2. By Component

            19.8.2.3. By Product 

            19.8.2.4. By Modality 

            19.8.2.5. By Patient Type  

    19.9. Russia Market Analysis

        19.9.1. Value Proportion Analysis by Market Taxonomy

        19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.9.2.1. By Provider

            19.9.2.2. By Component

            19.9.2.3. By Product 

            19.9.2.4. By Modality 

            19.9.2.5. By Patient Type  

    19.10. UK Market Analysis

        19.10.1. Value Proportion Analysis by Market Taxonomy

        19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.10.2.1. By Provider

            19.10.2.2. By Component

            19.10.2.3. By Product 

            19.10.2.4. By Modality 

            19.10.2.5. By Patient Type  

    19.11. China Market Analysis

        19.11.1. Value Proportion Analysis by Market Taxonomy

        19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.11.2.1. By Provider

            19.11.2.2. By Component

            19.11.2.3. By Product 

            19.11.2.4. By Modality 

            19.11.2.5. By Patient Type  

    19.12. Japan Market Analysis

        19.12.1. Value Proportion Analysis by Market Taxonomy

        19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.12.2.1. By Provider

            19.12.2.2. By Component

            19.12.2.3. By Product 

            19.12.2.4. By Modality 

            19.12.2.5. By Patient Type  

    19.13. South Korea Market Analysis

        19.13.1. Value Proportion Analysis by Market Taxonomy

        19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.13.2.1. By Provider

            19.13.2.2. By Component

            19.13.2.3. By Product 

            19.13.2.4. By Modality 

            19.13.2.5. By Patient Type  

    19.14. GCC Countries Market Analysis

        19.14.1. Value Proportion Analysis by Market Taxonomy

        19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.14.2.1. By Provider

            19.14.2.2. By Component

            19.14.2.3. By Product 

            19.14.2.4. By Modality 

            19.14.2.5. By Patient Type  

    19.15. South Africa Market Analysis

        19.15.1. Value Proportion Analysis by Market Taxonomy

        19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.15.2.1. By Provider

            19.15.2.2. By Component

            19.15.2.3. By Product 

            19.15.2.4. By Modality 

            19.15.2.5. By Patient Type  

    19.16. Turkey Market Analysis

        19.16.1. Value Proportion Analysis by Market Taxonomy

        19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            19.16.2.1. By Provider

            19.16.2.2. By Component

            19.16.2.3. By Product 

            19.16.2.4. By Modality 

            19.16.2.5. By Patient Type  

        19.16.3. Competition Landscape and Player Concentration in the Country

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies 

    20.2. Market Concentration

    20.3. Market Share Analysis of Top Players

    20.4. Market Presence Analysis

        20.4.1. By Regional footprint of Players

        20.4.2. Product footprint by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive 

        21.3.1. FRESENIUS MEDICAL CARE 

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Sales Footprint

            21.3.1.4. Strategy Overview

        21.3.2. GETINGE GROUP

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Sales Footprint

            21.3.2.4. Strategy Overview

        21.3.3. MEDTRONIC PLC

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Sales Footprint

            21.3.3.4. Strategy Overview

        21.3.4. MICROPORT

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Sales Footprint

            21.3.4.4. Strategy Overview

        21.3.5. TERUMO CARDIOVASCULAR SYSTEMS CORPORATION

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Sales Footprint

            21.3.5.4. Strategy Overview

        21.3.6. NIPRO CORPORATION

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Sales Footprint

            21.3.6.4. Strategy Overview

        21.3.7. LIVANOVA PLC

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Sales Footprint

            21.3.7.4. Strategy Overview

        21.3.8. EUROSETS S.R.L

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Sales Footprint

            21.3.8.4. Strategy Overview

        21.3.9. ORIGEN BIOMEDICAL, INC

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Sales Footprint

            21.3.9.4. Strategy Overview

        21.3.10. CYTOSORBENTS CORPORATION

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Sales Footprint

            21.3.10.4. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn),By Provider, 2015 – 2021

Table 2: Global Market Value (US$ Mn),By Provider, 2022 – 2032

Table 3: Global Market Value (US$ Mn), By Component, 2015 – 2021

Table 4: Global Market Value (US$ Mn), By Component, 2022 – 2032

Table 5: Global Market Value (US$ Mn), By Product , 2015 – 2021

Table 6: Global Market Value (US$ Mn), By Product , 2022 – 2032

Table 7: Global Market Value (US$ Mn), By Patient Type  , 2015 – 2021

Table 8: Global Market Value (US$ Mn), By Patient Type  , 2022 – 2032

Table 9: Global Market Value (US$ Mn), By Modality , 2015 – 2021

Table 10: Global Market Value (US$ Mn), By Modality , 2022 – 2032

Table 11: Global Market, By Region, 2015 – 2021

Table 12: Global Market, By Region, 2022 – 2032

Table 13: North America Market Value (US$ Mn),By Provider, 2015 – 2021

Table 14: North America Market Value (US$ Mn),By Provider, 2022 – 2032

Table 15: North America Market Value (US$ Mn), By Component, 2015 – 2021

Table 16: North America Market Value (US$ Mn), By Component, 2022 – 2032

Table 17: North America Market Value (US$ Mn), By Product , 2015 – 2021

Table 18: North America Market Value (US$ Mn), By Product , 2022 – 2032

Table 19: North America Market Value (US$ Mn), By Patient Type  , 2015 – 2021

Table 20: North America Market Value (US$ Mn), By Patient Type  , 2022 – 2032

Table 21: North America Market Value (US$ Mn), By Modality , 2015 – 2021

Table 22: North America Market Value (US$ Mn), By Modality , 2022 – 2032

Table 23: North America Market, By Country, 2015 – 2021

Table 24: North America Market, By Country, 2022 – 2032

Table 25: Latin America Market Value (US$ Mn),By Provider, 2015 – 2021

Table 26: Latin America Market Value (US$ Mn),By Provider, 2022 – 2032

Table 27: Latin America Market Value (US$ Mn), By Component, 2015 – 2021

Table 28: Latin America Market Value (US$ Mn), By Component, 2022 – 2032

Table 29: Latin America Market Value (US$ Mn), By Product , 2015 – 2021

Table 30: Latin America Market Value (US$ Mn), By Product , 2022 – 2032

Table 31: Latin America Market Value (US$ Mn), By Patient Type  , 2015 – 2021

Table 32: Latin America Market Value (US$ Mn), By Patient Type  , 2022 – 2032

Table 33: Latin America Market Value (US$ Mn), By Modality , 2015 – 2021

Table 34: Latin America Market Value (US$ Mn), By Modality , 2022 – 2032

Table 35: Latin America Market, By Country, 2015 – 2021

Table 36: Latin America Market, By Country, 2022 – 2032

Table 37: Europe Market Value (US$ Mn),By Provider, 2015 – 2021

Table 38: Europe Market Value (US$ Mn),By Provider, 2022 – 2032

Table 39: Europe Market Value (US$ Mn), By Component, 2015 – 2021

Table 40: Europe Market Value (US$ Mn), By Component, 2022 – 2032

Table 41: Europe Market Value (US$ Mn), By Product , 2015 – 2021

Table 42: Europe Market Value (US$ Mn), By Product , 2022 – 2032

Table 43: Europe Market Value (US$ Mn), By Patient Type  , 2015 – 2021

Table 44: Europe Market Value (US$ Mn), By Patient Type  , 2022 – 2032

Table 45: Europe Market Value (US$ Mn), By Modality , 2015 – 2021

Table 46: Europe Market Value (US$ Mn), By Modality , 2022 – 2032

Table 47: Europe Market, By Country, 2015 – 2021

Table 48: Europe Market, By Country, 2022 – 2032

Table 49: Asia Pacific Market Value (US$ Mn),By Provider, 2015 – 2021

Table 50: Asia Pacific Market Value (US$ Mn),By Provider, 2022 – 2032

Table 51: Asia Pacific Market Value (US$ Mn), By Component, 2015 – 2021

Table 52: Asia Pacific Market Value (US$ Mn), By Component, 2022 – 2032

Table 53: Asia Pacific Market Value (US$ Mn), By Product , 2015 – 2021

Table 54: Asia Pacific Market Value (US$ Mn), By Product , 2022 – 2032

Table 55: Asia Pacific Market Value (US$ Mn), By Patient Type  , 2015 – 2021

Table 56: Asia Pacific Market Value (US$ Mn), By Patient Type  , 2022 – 2032

Table 57: Asia Pacific Market Value (US$ Mn), By Modality , 2015 – 2021

Table 58: Asia Pacific Market Value (US$ Mn), By Modality , 2022 – 2032

Table 59: Asia Pacific Market, By Country, 2015 – 2021

Table 60: Asia Pacific Market, By Country, 2022 – 2032

Table 61: MEA Market Value (US$ Mn),By Provider, 2015 – 2021

Table 62: MEA Market Value (US$ Mn),By Provider, 2022 – 2032

Table 63: MEA Market Value (US$ Mn), By Component, 2015 – 2021

Table 64: MEA Market Value (US$ Mn), By Component, 2022 – 2032

Table 65: MEA Market Value (US$ Mn), By Product , 2015 – 2021

Table 66: MEA Market Value (US$ Mn), By Product , 2022 – 2032

Table 67: MEA Market Value (US$ Mn), By Patient Type  , 2015 – 2021

Table 68: MEA Market Value (US$ Mn), By Patient Type  , 2022 – 2032

Table 69: MEA Market Value (US$ Mn), By Modality , 2015 – 2021

Table 70: MEA Market Value (US$ Mn), By Modality , 2022 – 2032

Table 71: MEA Market, By Country, 2015 – 2021

Table 72: MEA Market, By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Market Share,By Provider, 2022 & 2032

Figure 4: Global Market Y-o-Y Growth Projections,By Provider – 2022-2032

Figure 5: Global Market Attractiveness Index,By Provider – 2022-2032

Figure 6: Global Market Share, By Component, 2022 & 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Component – 2022-2032

Figure 8: Global Market Attractiveness Index, By Component – 2022-2032

Figure 9: Global Market Share, By Patient Type  , 2022 & 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Patient Type   – 2022-2032

Figure 11: Global Market Attractiveness Index, By Patient Type   – 2022-2032

Figure 12: Global Market Share, By Product , 2022 & 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Product  – 2022-2032

Figure 14: Global Market Attractiveness Index, By Product  – 2022-2032

Figure 15: Global Market Share, By Modality , 2022 & 2032

Figure 16: Global Market Y-o-Y Growth Projections, By Modality  – 2022-2032

Figure 17: Global Market Attractiveness Index, By Modality  – 2022-2032

Figure 18: Global Market Share, By Region, 2022 & 2032

Figure 19: Global Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 20: Global Market Attractiveness Index, By Region – 2022-2032

Figure 21: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 22: North America Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 23: North America Market Share,By Provider, 2022 & 2032

Figure 24: North America Market Y-o-Y Growth Projections,By Provider – 2022-2032

Figure 25: North America Market Attractiveness Index,By Provider – 2022-2032

Figure 26: North America Market Share, By Component, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Component – 2022-2032

Figure 28: North America Market Attractiveness Index, By Component – 2022-2032

Figure 29: North America Market Share, By Patient Type  , 2022 & 2032

Figure 30: North America Market Y-o-Y Growth Projections, By Patient Type   – 2022-2032

Figure 31: North America Market Attractiveness Index, By Patient Type   – 2022-2032

Figure 32: North America Market Share, By Product , 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Product  – 2022-2032

Figure 34: North America Market Attractiveness Index, By Product  – 2022-2032

Figure 35: North America Market Share, By Modality , 2022 & 2032

Figure 36: North America Market Y-o-Y Growth Projections, By Modality  – 2022-2032

Figure 37: North America Market Attractiveness Index, By Modality  – 2022-2032

Figure 38: North America Market Share, By Country, 2022 & 2032

Figure 39: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 40: North America Market Attractiveness Index, By Country – 2022-2032

Figure 41: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 42: Latin America Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 43: Latin America Market Share,By Provider, 2022 & 2032

Figure 44: Latin America Market Y-o-Y Growth Projections,By Provider – 2022-2032

Figure 45: Latin America Market Attractiveness Index,By Provider – 2022-2032

Figure 46: Latin America Market Share, By Component, 2022 & 2032

Figure 47: Latin America Market Y-o-Y Growth Projections, By Component – 2022-2032

Figure 48: Latin America Market Attractiveness Index, By Component – 2022-2032

Figure 49: Latin America Market Share, By Patient Type  , 2022 & 2032

Figure 50: Latin America Market Y-o-Y Growth Projections, By Patient Type   – 2022-2032

Figure 51: Latin America Market Attractiveness Index, By Patient Type   – 2022-2032

Figure 52: Latin America Market Share, By Product , 2022 & 2032

Figure 53: Latin America Market Y-o-Y Growth Projections, By Product  – 2022-2032

Figure 54: Latin America Market Attractiveness Index, By Product  – 2022-2032

Figure 55: Latin America Market Share, By Modality , 2022 & 2032

Figure 56: Latin America Market Y-o-Y Growth Projections, By Modality  – 2022-2032

Figure 57: Latin America Market Attractiveness Index, By Modality  – 2022-2032

Figure 58: Latin America Market Share, By Country, 2022 & 2032

Figure 59: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 60: Latin America Market Attractiveness Index, By Country – 2022-2032

Figure 61: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 62: Europe Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 63: Europe Market Share,By Provider, 2022 & 2032

Figure 64: Europe Market Y-o-Y Growth Projections,By Provider – 2022-2032

Figure 65: Europe Market Attractiveness Index,By Provider – 2022-2032

Figure 66: Europe Market Share, By Component, 2022 & 2032

Figure 67: Europe Market Y-o-Y Growth Projections, By Component – 2022-2032

Figure 68: Europe Market Attractiveness Index, By Component – 2022-2032

Figure 69: Europe Market Share, By Patient Type  , 2022 & 2032

Figure 70: Europe Market Y-o-Y Growth Projections, By Patient Type   – 2022-2032

Figure 71: Europe Market Attractiveness Index, By Patient Type   – 2022-2032

Figure 72: Europe Market Share, By Product , 2022 & 2032

Figure 73: Europe Market Y-o-Y Growth Projections, By Product  – 2022-2032

Figure 74: Europe Market Attractiveness Index, By Product  – 2022-2032

Figure 75: Europe Market Share, By Modality , 2022 & 2032

Figure 76: Europe Market Y-o-Y Growth Projections, By Modality  – 2022-2032

Figure 77: Europe Market Attractiveness Index, By Modality  – 2022-2032

Figure 78: Europe Market Share, By Country, 2022 & 2032

Figure 79: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 80: Europe Market Attractiveness Index, By Country – 2022-2032

Figure 81: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 82: Asia Pacific Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 83: Asia Pacific Market Share,By Provider, 2022 & 2032

Figure 84: Asia Pacific Market Y-o-Y Growth Projections,By Provider – 2022-2032

Figure 85: Asia Pacific Market Attractiveness Index,By Provider – 2022-2032

Figure 86: Asia Pacific Market Share, By Component, 2022 & 2032

Figure 87: Asia Pacific Market Y-o-Y Growth Projections, By Component – 2022-2032

Figure 88: Asia Pacific Market Attractiveness Index, By Component – 2022-2032

Figure 89: Asia Pacific Market Share, By Patient Type  , 2022 & 2032

Figure 90: Asia Pacific Market Y-o-Y Growth Projections, By Patient Type   – 2022-2032

Figure 91: Asia Pacific Market Attractiveness Index, By Patient Type   – 2022-2032

Figure 92: Asia Pacific Market Share, By Product , 2022 & 2032

Figure 93: Asia Pacific Market Y-o-Y Growth Projections, By Product  – 2022-2032

Figure 94: Asia Pacific Market Attractiveness Index, By Product  – 2022-2032

Figure 95: Asia Pacific Market Share, By Modality , 2022 & 2032

Figure 96: Asia Pacific Market Y-o-Y Growth Projections, By Modality  – 2022-2032

Figure 97: Asia Pacific Market Attractiveness Index, By Modality  – 2022-2032

Figure 98: Asia Pacific Market Share, By Country, 2022 & 2032

Figure 99: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 100: Asia Pacific Market Attractiveness Index, By Country – 2022-2032

Figure 101: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 102: MEA Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 103: MEA Market Share,By Provider, 2022 & 2032

Figure 104: MEA Market Y-o-Y Growth Projections,By Provider – 2022-2032

Figure 105: MEA Market Attractiveness Index,By Provider – 2022-2032

Figure 106: MEA Market Share, By Component, 2022 & 2032

Figure 107: MEA Market Y-o-Y Growth Projections, By Component – 2022-2032

Figure 108: MEA Market Attractiveness Index, By Component – 2022-2032

Figure 109: MEA Market Share, By Patient Type  , 2022 & 2032

Figure 110: MEA Market Y-o-Y Growth Projections, By Patient Type   – 2022-2032

Figure 111: MEA Market Attractiveness Index, By Patient Type   – 2022-2032

Figure 112: MEA Market Share, By Product , 2022 & 2032

Figure 113: MEA Market Y-o-Y Growth Projections, By Product  – 2022-2032

Figure 114: MEA Market Attractiveness Index, By Product  – 2022-2032

Figure 115: MEA Market Share, By Modality , 2022 & 2032

Figure 116: MEA Market Y-o-Y Growth Projections, By Modality  – 2022-2032

Figure 117: MEA Market Attractiveness Index, By Modality  – 2022-2032

Figure 118: MEA Market Share, By Country, 2022 & 2032

Figure 119: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 120: MEA Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pain Management Devices Market

Published : February 2022

Healthcare

Extracorporeal Membrane Oxygenation Machine Market

Published : February 2022

Healthcare

Wearable Healthcare Devices Market

Published : February 2022

Healthcare

Mucous Membrane Pemphigoid Treatment Market

Published : February 2019

Google translate

Extracorporeal Membrane Oxygenation Machine Market